Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006

Hamid, O; Robert, C; Ribas, A; Hodi, FS; Walpole, E; Daud, A; Arance, AS; Brown, E; Hoeller, C; Mortier, L; Schachter, J; Long, J; Ebbinghaus, S; Ibrahim, N; Butler, M

Hamid, O (reprint author), Angeles Clin & Res Inst, Los Angeles, CA 90025 USA.

BRITISH JOURNAL OF CANCER, 2018; 119 (6): 670

Abstract

BACKGROUND: Mucosal melanoma is an aggressive melanoma with poor prognosis. We assessed efficacy of pembrolizumab in patients with advanced mucosal me......

Full Text Link